IL10 and neoplasm: TAMs directly inhibit CTLs through immune checkpoint engagement by expressing programmed cell death ligand 1 (PD-L1) and B7-H4, secreting inhibitory cytokines IL-10 and TGF-β, and depleting metabolites such as L-arginine, which is essential for T cell fitness and anti-tumor activity 249.